Please provide your email address to receive an email when new articles are posted on . Although patients may be safely discharged to home following total knee arthroplasty, published results showed ...

Following COVID-19–related lockdown measures, preferences for the use of biologics among Japanese patients with psoriasis addressed administration route, visits, and risk of serious infections ...

Though the highest ranking preferences at baseline were observed to be efficacy and tolerability, DMT selection was ultimately linked more closely with safety preferences than with efficacy, ...

A discussion on the patient preference for specific medications based on administration and dosing schedule, and the payer approval process. Transcript Peter L. Salgo, MD: Well, with that, what role ...

When it comes to medicine, catering to convenience and patient preference can have life-changing results. Ease of use can influence treatment pathways, long-term adherence, and ultimately clinical ...

Please provide your email address to receive an email when new articles are posted on . A recent survey of some 2,000 Americans on the topic of telemedicine revealed a swift and dramatic shift in ...

It’s a fact: “consumerism” has arrived in healthcare. That means providers are redoubling efforts to deliver patient-centered care and actively engage patients in their healthcare decisions. In some ...

ARLINGTON, Va.--(BUSINESS WIRE)--The Health Economics and Patient Value (HEPV) initiative at the Medical Device Innovation Consortium (MDIC) has released the white paper, How Can Patient Preference ...

Association Between Genetic Testing for Hereditary Breast Cancer and Contralateral Prophylactic Mastectomy Among Multiethnic Women Diagnosed With Early-Stage Breast Cancer Among 380 respondents, most ...

Fewer Americans are using telehealth compared to earlier in the pandemic, a new survey has found. Stericycle Communication Solutions, a patient engagement solutions vendor, released the results of its ...

Bendamustine plus rituximab (B-R) versus CHOP plus rituximab (CHOP-R) as first-line treatment in patients with indolent and mantle cell lymphomas (MCL): Updated results from the StiL NHL1 study. This ...

The FDA is polling the industry and the public for ideas on where the agency should focus when it comes to addressing patient preferences for medical devices, to help build out its new list of ...